Jazbec J - Search Results

1

RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.

Podgornik H, Debeljak M, Zontar D, Cernelc P, Prestor VV, Jazbec J. Podgornik H, et al. Among authors: jazbec j. Cancer Genet Cytogenet. 2007 Oct 1;178(1):77-81. doi: 10.1016/j.cancergencyto.2007.06.015. Cancer Genet Cytogenet. 2007. PMID: 17889714

2

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia.

Jazbec J, Aplenc R, Dolzan V, Debeljak M, Jereb B. Jazbec J, et al. Leukemia. 2003 Dec;17(12):2540-2. doi: 10.1038/sj.leu.2403164. Leukemia. 2003. PMID: 14523457 No abstract available.

3

No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia.

Jazbec J, Kitanovski L, Aplenc R, Debeljak M, Dolzan V. Jazbec J, et al. Leuk Lymphoma. 2005 Jun;46(6):893-7. doi: 10.1080/10428190500086428. Leuk Lymphoma. 2005. PMID: 16019535

4

X-linked lymphoproliferative disease with a novel SH2D1A gene mutation.

Debeljak M, Podkrajsek KT, Aplenc R, Jazbec J. Debeljak M, et al. Among authors: jazbec j. Pediatr Blood Cancer. 2008 Jan;50(1):187. doi: 10.1002/pbc.21216. Pediatr Blood Cancer. 2008. PMID: 17455312 No abstract available.

5

5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia (ALL).

Karas Kuzelicki N, Milek M, Jazbec J, Mlinaric-Rascan I. Karas Kuzelicki N, et al. Among authors: jazbec j. Leuk Res. 2009 Oct;33(10):1344-8. doi: 10.1016/j.leukres.2008.12.011. Leuk Res. 2009. PMID: 19178944

6

A patient with Baller-Gerold syndrome and midline NK/T lymphoma.

Debeljak M, Zver A, Jazbec J. Debeljak M, et al. Among authors: jazbec j. Am J Med Genet A. 2009 Feb 15;149A(4):755-9. doi: 10.1002/ajmg.a.32736. Am J Med Genet A. 2009. PMID: 19291770

7

Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood.

Rajić V, Aplenc R, Debeljak M, Prestor VV, Karas-Kuzelicki N, Mlinaric-Rascan I, Jazbec J. Rajić V, et al. Among authors: jazbec j. Leuk Lymphoma. 2009 Oct;50(10):1693-8. doi: 10.1080/10428190903177212. Leuk Lymphoma. 2009. PMID: 19863340

8

Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.

Erčulj N, Kotnik BF, Debeljak M, Jazbec J, Dolžan V. Erčulj N, et al. Among authors: jazbec j. Leuk Lymphoma. 2012 Jun;53(6):1096-104. doi: 10.3109/10428194.2011.639880. Epub 2012 Feb 3. Leuk Lymphoma. 2012. PMID: 22074251

9

DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia.

Erčulj N, Faganel Kotnik B, Debeljak M, Jazbec J, Dolžan V. Erčulj N, et al. Among authors: jazbec j. J Cancer Res Clin Oncol. 2012 Nov;138(11):1919-30. doi: 10.1007/s00432-012-1265-4. Epub 2012 Jul 1. J Cancer Res Clin Oncol. 2012. PMID: 22752646

10

Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset.

Debeljak M, Kitanovski L, Pajič T, Jazbec J. Debeljak M, et al. Among authors: jazbec j. Haematologica. 2013 Jul;98(7):e73-4. doi: 10.3324/haematol.2012.082578. Epub 2013 May 28. Haematologica. 2013. PMID: 23716546 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters